Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Mahipal

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
Cancer Control : Journal of the Moffitt Cancer Center|July 2, 2013
Role of systemic chemotherapy in urothelial urinary bladder cancerShilpa Gupta, Amit Mahipal
Cancer Control : Journal of the Moffitt Cancer Center|June 24, 2014
Risks and benefits of phase 1 clinical trial participationAmit Mahipal, Danny Nguyen
Journal of Oncology Practice|December 13, 2016
Role of Biologics in First-Line Treatment of Colorectal CancerAmit Mahipal, Axel Grothey
Pharmacotherapy|March 27, 2007
Fatal pulmonary toxicity after a single dose of cyclophosphamideShilpa Gupta, Amit Mahipal
Pharmacology & Therapeutics|April 27, 2016
Importins and exportins as therapeutic targets in cancerAmit Mahipal, Mokenge Malafa
Cancer Control : Journal of the Moffitt Cancer Center|June 24, 2014
Participation of the elderly population in clinical trials: barriers and solutionsAaron C Denson, Amit Mahipal
Current Oncology (Toronto, Ont.)|January 22, 2024
Adoption of Total Neoadjuvant Therapy in the Treatment of Locally Advanced Rectal CancerMadison L Conces, Amit Mahipal
Expert Opinion on Pharmacotherapy|October 18, 2022
An evaluation of ivosidenib for the treatment of <i>IDH1</i>-mutant cholangiocarcinomaSri Harsha Tella, Amit Mahipal
Expert Review of Clinical Pharmacology|August 8, 2025
Current state, challenges, unmet needs, and future directions in the pharmacological treatment of biliary tract cancerMichael H Storandt, Amit Mahipal
Biomedicines|January 25, 2025
Toxicity Associated with Pembrolizumab Monotherapy in Patients with Gastrointestinal Cancers: A Systematic Review of Clinical TrialsNikolas Naleid, Amit Mahipal, Sakti Chakrabarti
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
Cancer Control : Journal of the Moffitt Cancer Center|July 2, 2013
Role of systemic chemotherapy in urothelial urinary bladder cancerShilpa Gupta, Amit Mahipal
Cancer Control : Journal of the Moffitt Cancer Center|June 24, 2014
Risks and benefits of phase 1 clinical trial participationAmit Mahipal, Danny Nguyen
Journal of Oncology Practice|December 13, 2016
Role of Biologics in First-Line Treatment of Colorectal CancerAmit Mahipal, Axel Grothey
Pharmacotherapy|March 27, 2007
Fatal pulmonary toxicity after a single dose of cyclophosphamideShilpa Gupta, Amit Mahipal
Pharmacology & Therapeutics|April 27, 2016
Importins and exportins as therapeutic targets in cancerAmit Mahipal, Mokenge Malafa
Cancer Control : Journal of the Moffitt Cancer Center|June 24, 2014
Participation of the elderly population in clinical trials: barriers and solutionsAaron C Denson, Amit Mahipal
Current Oncology (Toronto, Ont.)|January 22, 2024
Adoption of Total Neoadjuvant Therapy in the Treatment of Locally Advanced Rectal CancerMadison L Conces, Amit Mahipal
Expert Opinion on Pharmacotherapy|October 18, 2022
An evaluation of ivosidenib for the treatment of <i>IDH1</i>-mutant cholangiocarcinomaSri Harsha Tella, Amit Mahipal
Expert Review of Clinical Pharmacology|August 8, 2025
Current state, challenges, unmet needs, and future directions in the pharmacological treatment of biliary tract cancerMichael H Storandt, Amit Mahipal
Biomedicines|January 25, 2025
Toxicity Associated with Pembrolizumab Monotherapy in Patients with Gastrointestinal Cancers: A Systematic Review of Clinical TrialsNikolas Naleid, Amit Mahipal, Sakti Chakrabarti
Pageof 18